Black Diamond Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Black Diamond Therapeutics Inc 's ROA in the second quarter of 2026?
Black Diamond Therapeutics Inc recorded a cumulative net loss of $-43 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -30.47%.

However, within the Healthcare sector 426 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 451 to 3625.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-24.86 %	-24.58 %	38.09 %	32.54 %	27.68 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-43	-43	22	21	14
Return On Assets (TTM)	-30.47 %	-28.8 %	13.91 %	14.24 %	10.22 %
BDTX's Total Ranking	# 3625	# 451	# 405	# 648	# 1486
Total Assets (TTM) in million	125	133	143	158	166
Seq. Total Assets Change	-5.94 %	-7.05 %	-9.33 %	-5.2 %	-5.59 %
Seq. Net Income Change	-	-	-	-	-

BDTX's 5 Years Annual ROA >> Back to BDTX Management Effectiveness >> Compare BDTX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 44
Sector	# 427
Overall	# 3614

Return On Assets Statistics
High	Average	Low
57.53 %	-27.91 %	-57.6 %
(Mar 31 2020)		(Sep 30 2023)

Financial Statements
Black Diamond Therapeutics Inc 's Assets	$ 125 million	BDTX's Balance sheet
Black Diamond Therapeutics Inc 's Income	$ -10 million	Quarterly BDTX's Income Statement
BDTX's Income by Division		See BDTX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	38.09 %	-23.72 %	4.2 %	-40.71 %	-33.35 %
Total Assets in million	143	104	136	130	220
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	22	-70	-82	-91	-126
Annual Return On Assets	15.64 %	-67.28 %	-60.72 %	-69.97 %	-57.16 %

BDTX's 5 Years Annual ROA >> Back to BDTX Management Effectiveness >> Compare BDTX ROA to its Competitors

Comment on BDTX's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 15.64 % compared to prior year, due to annual net income growth of % to $22.37 million, while value of Black Diamond Therapeutics Inc 's overall assets grew just by 38.09 % to $143.01 million, compared to $143.01 a year before.

More Return On Assets Ratios
BDTX's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BDTX's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BDTX's Competitors
Subscribers only: Roa for Black Diamond Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for BDTX's Customers

You may also want to know
BDTX's Roi	BDTX's Inventory Turnover Ratio	BDTX's Growth Rates	BDTX's Dividend Comparisons
	BDTX's Profitability Ratios	BDTX's Asset Turnover Ratio	BDTX's Dividend Growth
BDTX's Roe	BDTX's Valuation Ratios	BDTX's Financial Strength Ratios	BDTX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-09T01:59:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.